Abstract
Human Metapneumovirus (HMPV) is a common respiratory virus that affects people of all ages, especially young children, the elderly, and those with weakened immune systems. It can cause respiratory illnesses, ranging from mild symptoms to serious conditions like bronchiolitis and pneumonia. HMPV is an RNA virus that spreads easily through respiratory droplets, direct contact with infected surfaces, or touching contaminated objects. People at higher risk include infants, the elderly, those with weakened immune systems, and individuals with respiratory issues like asthma or COPD. In severe cases, it can lead to hospitalization or, rarely, death. Coinfections with viruses like RSV or influenza can make symptoms worse. HMPV is diagnosed using advanced molecular tests like RT-PCR, antigen detection methods, such as immunofluorescence and enzyme immunoassays. Treatment focuses on supportive care, while prevention involves good hygiene and infection control. Promising research is underway to develop vaccines and antibody therapies to help reduce its impact. This paper explores the virus, its effects, diagnosis, treatment, and ongoing research efforts.
Keywords: HMPV, Infections, Respiratory, Vaccines.